A Phase II, Multicenter,Randomization, Double-Blind, Parallel Group, Placebo-Controlled, Forced Titration Proof of Concept Study to Assess Efficacy, Safety, Tolerability and the Therapeutic Ratio of ASP7035 in Patients with Nocturia Associated with Norturnal Polyuria
AN OPEN LABEL STUDY TO EVALUATE THE PHARMACOKINETICS OF ASP7035 AFTER A SINGLE ORAL DOSE OF 14C-LABELED ASP7035 IN HEALTHY MALE SUBJECTS - ASP7035 MB
100 项与 ASP-7035 相关的专利(医药)